Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats
- 31 August 1996
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 68 (1-2) , 1-11
- https://doi.org/10.1016/0165-5728(96)00051-3
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2European Journal of Immunology, 1995
- Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.Journal of Clinical Investigation, 1994
- Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1‐ but not type 2‐associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis ratsEuropean Journal of Immunology, 1993
- A New Cyclic Nucleotide Phosphodiesterase Isozyme Expressed in the T-Lymphocyte Cell LinesBiochemical and Biophysical Research Communications, 1993
- Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells.The Journal of Experimental Medicine, 1992
- Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.Thorax, 1991
- Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.The Journal of Experimental Medicine, 1990
- Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitorsTrends in Pharmacological Sciences, 1990
- Migration of lymphocytes through endothelial cell monolayers: Augmentation by interferon-γCellular Immunology, 1988
- The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune responseImmunology Today, 1988